February 10, 2014
Program in Evidence-based Care
- Bortezomib in multiple myeloma and lymphoma. This updates a previously published guideline summary.
- Routine HPV testing in head and neck squamous cell carcinoma.
martes, 11 de febrero de 2014
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario